Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
BMRAthis companyBiomerica, Inc.	$1.55	-1.82×	2.62×	1.54×	-1.62×	-596.1%	8.1%	-119.5%	-84.8%	-143.5%	-106.1%	-49.7%	0.91×	-0.22×	0×	1.62×	0.0%	1	-10.29	2	C
ALZNAlzamend Neuro Inc	$1.40	-0.43×	5.19×	0×	-0.36×	-113.5%	0.0%	0.0%	0.0%	-1196.4%	-1195.7%	-212.1%	0×	0.08×	1,324.5×	1.31×	0.0%	1	-12.93	2	C
CELZCreative Medical Technology Holdings, Inc.	$0.64	-0.78×	0.62×	778.38×	0.42×	371.4%	63.4%	-102380.2%	-99916.8%	-79.8%	-81.5%	-125.4%	0×	1.2×	0×	25.97×	0.0%	1	-10.71	2	B-
HSCSHeartSciences Inc.	$2.95	-0.56×	0.02×	1,185.36×	-275.91×	-25040.1%	-2982.1%	-194787.4%	-211666.5%	-4.1%	-0.2%	-145.9%	17.46×	-275.29×	-11.17×	0.53×	0.0%	1	-41.58	2	C
LUCYLucyd, Inc	$0.84	-0.52×	0.44×	1.49×	0.34×	-2524.3%	21.3%	-319.2%	-285.2%	-83.7%	-93.4%	-189.2%	0×	0.87×	0×	9.03×	0.0%	3	-1.19	2	C+
PAVMPAVmed Inc.	$1.45	-1.18×	0.13×	62.51×	-6.93×	-1105.0%	-354.9%	-30712.7%	564.8%	1.2%	-61.2%	-117292.3%	0.39×	-5.04×	-1,038.38×	0.17×	0.0%	2	-10.09	2	C
Peer median	—	-0.56×	0.44×	62.51×	-0.36×	-1105.0%	0.0%	-30712.7%	-285.2%	-79.8%	-81.5%	-189.2%	0×	0.08×	0×	1.31×	0.0%	1	-10.71	2	—